Analysis of Cell Immunity for Children Infected with SARS-CoV-2 and Those Vaccinated against SARS-CoV-2 Using T-SPOT®.COVID
Open Access
- 13 May 2024
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 12 (5) , 975
Abstract
Cellular immunity is critical for the regulation of viral diseases, including coronavirus disease 2019 (COVID-19), and is generally considered immature in childhood. However, the details of cellular immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among children are unclear. We assessed cellular immunity in eight children post-vaccination against SARS-CoV-2 and 11 children after SARS-CoV-2 infection using the T-SPOT®.COVID assay for the spike (S) and nucleocapsid (N) proteins. In the vaccinated group, the T-SPOT®.COVID assay for the S protein yielded positive results in seven children. In the post-infection group, the assay for the N protein was positive for 5 of 11 children, with 3 of these 5 children requiring hospitalization, including 2 who needed mechanical ventilation. The T-SPOT®.COVID assay is thus valuable for assessing cellular immunity against SARS-CoV-2, and most children infected with SARS-CoV-2 may not develop such immunity unless the disease severity is significant.Keywords
All Related Versions
This publication has 16 references indexed in Scilit:
- Immune cell landscape in symptomatic and asymptomatic SARS-CoV-2 infected adults and children in urban Dhaka, BangladeshImmunobiology, 2023
- Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individualsJournal of Clinical Virology, 2022
- Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 OmicronNature, 2022
- SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort studyJournal of Infection, 2021
- Differential Kinetics of Immune Responses Elicited by Covid-19 VaccinesNew England Journal of Medicine, 2021
- T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individualsCellular & Molecular Immunology, 2021
- SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infectionNature Communications, 2021
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralizationNature, 2021
- Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassayInternational Journal of Infectious Diseases, 2021
- Immune Deficiencies at the Extremes of Age2019